Geraniol and simvastatin show a synergistic effect on a human hepatocarcinoma cell line

Cell Biochemistry and Function

Volumn 29, Issue 6, 2011, Pages 452-458

  Polo, M P ^a,b   Crespo, R ^a,b,c   de Bravo, M G ^a,b,c  

^a INSTITUTO DE INVESTIGACIONES BIOQUÍMICAS DE LA PLATA INIBIOLP   (Argentina)

^b FACULTAD DE CIENCIAS MÉDICAS   (Argentina)

^c Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

Author keywords

Cell proliferation; Cholesterogenesis; Geraniol; Phospholipids; Simvastatin

Indexed keywords

ACETIC ACID; CHOLESTEROL; FATTY ACID; GERANIOL; LANOSTEROL; LIPID; PHOSPHATIDYLINOSITOL; SIMVASTATIN; SPHINGOMYELIN; SQUALENE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER PREVENTION; CARCINOMA CELL; CARDIOVASCULAR DISEASE; CELL LEVEL; CELL PROLIFERATION; CELL VIABILITY; CHOLESTEROL SYNTHESIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG POTENTIATION; HUMAN; HUMAN CELL; IN VITRO STUDY; LIPID ANALYSIS; LIPOGENESIS; LIVER CELL CARCINOMA; METABOLISM; PRIORITY JOURNAL;

ACETATES; CARCINOMA, HEPATOCELLULAR; CELL PROLIFERATION; CHOLESTEROL; ENZYME INHIBITORS; HEP G2 CELLS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LIPIDS; LIVER NEOPLASMS; SIMVASTATIN; TERPENES;

EID: 80051671114     PISSN: 02636484     EISSN: 10990844     Source Type: Journal    
DOI: 10.1002/cbf.1772     Document Type: Article

References (49)

1. Goldstein JL, Brown MS. Regulation of the mevalonate pathway. Nature (London) 1990; 343: 425-430.
2. Maltese WA. Posttranslational modification of proteins by isoprenoids in mammalian cells. FASEB J 1990; 4: 3319-3328.
3. Grünler J, Ericsson J, Dallner G. Branch-point reactions in the biosynthesis of cholesterol, dolichol, ubiquinone and prenylated proteins. Biochim Biophys Acta 1994; 1212: 259-277.
4. Glomset JA, Gelb MH, Farnsworth CC. Prenyl proteins in eukaryotic cells: a new type of membrane anchor. Trends Biochem Sci 1990; 15: 139-142.
5. Downs JR, Clearfield M, Weis S, et al. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study. JAMA 1998; 279: 1615-1622.
6. Sacks FM, Pfeffer MA, Moye LA, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and recurrent events trial investigators. N Engl J Med 1996; 335: 1001-1009.
7. Bucher HC, Griffith LE, Guyatt GH. Effect of HMGcoA reductase inhibitors on stroke. A meta-analysis of randomized, controlled trials. Ann Intern Med 1998; 128: 89-95.
8. Byington RP, Davis BR, Plehn JF, et al. Reduction of stroke events with pravastatin: the prospective pravastatin pooling (PPP) project. Circulation 2001; 103: 387-392.
9. Farmer JA. Pleiotropic effects of statins. Curr Atheroscler Rep 2000; 2: 208-217.
10. La Rosa JC. Pleitropic effects of statins and their clinical significance. Am J Med Assoc 2001; 285: 1711-1718.
11. Bellosta S, Ferri N, Bernini F, Paoletti R, Corsini A. Non lipid related effects of statins. Ann Med 2000; 32: 164-176.
12. Greenwood J, Steinman L, Zamvil SS. Statin therapy and autoimmune disease: from protein prenylation to immunomodulation. Nat Rev Immunol 2006; 6: 358-370.
13. Ali F, Zakkar M, Karu K, et al. Induction of the cytoprotective enzyme heme oxygenase-1 by statins is enhanced in vascular endothelium exposed to laminar shear stress and impaired by disturbed flow. J Biol Chem 2009; 284: 18882-18892.
14. Vaughn CJ, Gotto AM, Jr. Update on statins: 2003. Circulation 2004; 110: 886-892.
15. Crowell PL. Prevention and therapy of cancer by dietary monoterpenes. J Nutr 1999; 129: 775S-778S.
16. Swanson KM, Hohl RJ. Anti-cancer therapy: targeting the mevalonate pathway. Curr Cancer Drug Targets 2006; 6: 15-37.
17. Sebti SM, Tkalcevit GT, Jani JP. Lovastatin, a Cholesterol Biosynthesis Inhibitor, Inhibits the Growth of Human H-Ras Oncogene Transformed Cells in Nude Mice. Cancer Commun 1991; 3: 141-147.
18. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein Measurement with Folin Phenol Reagent. J Biol Chem 1951; 193: 256-275.
19. Jauregui HO, Hayner NT, Driscoll JL, Williams-Holland R, Lipsky MH, Galletti PM. Trypan blue dye uptake and lactate dehydrogenase in adult rat hepatocytes freshly isolated cells, cell suspensions, and primary monolayer cultures. In Vitro 1981; 17: 1100-1110.
20. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983; 65: 55-63.
21. Folch J, Lees M, Sloane Stanley GH. A simple method for the isolation and purification of total lipids from animals tissues. J Biol Chem 1957; 226: 497-509.
22. Christie WW, Han X. The analysis of simple lipid classes. In Lipid Analysis. Isolation, separation, identification and lipidomic analysis. The Oil Press: Bridgwater, 2010; 72.
23. Maltese WA, Sheridan KM. Differentiation of neuroblastoma cells induced by an inhibitor of mevalonate synthesis: relation of neurite outgrowth and acetylcholinesterase activity to changes in cell proliferation and blocked isoprenoid synthesis. J Cell Physiol 1985; 125: 540-558.
24. Malins DC, Mangold HK. Analysis of complex lipid mixtures by thin layer chromatographic and complementary methods. J Am Oil Chem Soc 1960; 37: 576-582.
25. Holub BJ, Skeaff CM. Nutritional regulation of cellular phosphatidylinositol. Methods Enzymol 1987; 141: 234-244.
26. Agarwal B, Bhendwal S, Halmos B, Moss SF, Ramey WG, Holt PR. Lovastatin Augments Apoptosis Induced by Chemotherapeutic Agents in Colon Cancer Cells. Clin Cancer Res 1999; 5: 2223-2229.
27. Carnesecchi S, Bras-Gonçalves R, Bradaia A, et al. Geraniol, a component of plant essential oils, modulates DNA synthesis and potentiates 5-fluorouracil efficacy on human colon tumor xenografts. Cancer Lett 2004; 215: 53-59.
28. Soma MR, Pagliarini P, Butti G, Paoletti R, Paoletti P, Fumagalli R. Simvastatin, an inhibitor of cholesterol biosynthesis, shows a synergistic effect with N, N'-Bis(2-chloroethyl)-N-nitrosourea and beta-interferon on human glioma cells. Cancer Res 1992; 52: 4348-4355.
29. Feleszko W, Zagozdzon R, Golab J, Jakóbisiak M. Potentiated antitumour effects of cisplatin and lovastatin against MmB16 melanoma in mice. Eur J Cancer 1998; 34: 406-411.
30. Feleszko W, Mlynarczuk I, Balkowiec-Iskra EZ, et al. Lovastatin potentiates antitumor activity and attenuates cardiotoxicity of doxorubicin in three tumor models in mice. Clin Cancer Res 2000; 6: 2044-2052.
31. Holstein SA, Hohl RJ. Synergistic interaction of lovastatin and paclitaxel in human cancer cells. Mol Cancer Ther 2001; 1: 141-149.
32. Kozar K, Kaminski R, Legat M, et al. Cerivastatin demonstrates enhanced antitumor activity against human breast cancer cell lines when used in combination with doxorubicin or cisplatin. Int J Oncol 2004; 24: 1149-1157.
33. Holstein SA, Hohl RJ. Interaction of cytosine arabinoside and lovastatin in human leukemia cells. Leuk Res 2001; 25: 651-660.
34. Lishner M, Bar-Sef A, Elis A, Fabian I. Effect of simvastatin alone and in combination with cytosine arabinoside on the proliferation of myeloid leukemia cell lines. J Investig Med 2001; 49: 319-324.
35. Bocci G, Fioravanti A, Orlandi P, et al. Fluvastatin synergistically enhances the antiproliferative effect of gemcitabine in human pancreatic cancer MIAPaCa-2 cells. Br J Cancer 2005; 93: 319-330.
36. Mo H, Elson CE. Studies of the isoprenoid-mediated inhibition of mevalonate synthesis applied to cancer chemotherapy and chemoprevention. Exp Biol Med 2004; 229: 567-585.
37. Mo H, Elson CE. Apoptosis and cell-cycle arrest in human and murine tumor cells are initiated by isoprenoids. J Nutr 1999; 129: 804-813.
38. McAnally JA, Gupta J, Sodhani S, Bravo L, Mo H. Tocotrienols Potentiate Lovastatin-Mediated Growth Suppression In Vitro and In Vivo. Exp Biol Med (Maywood) 2007; 232: 523-31.
39. Wali VB, Sylvester PW. Synergistic antiproliferative effects of γ-tocotrienol and statin treatment on mammary tumor cells. Lipids 2007; 42: 1113-1123.
40. Wali VB, Bachawal SV, Silvestre PW. Combined Treatment of γ-Tocotrienol with Statins Induce Mammary Tumor Cell Cycle Arrest in G1. Exp Biol Med 2009; 234: 639-650.
41. Llaverí G, Jové M, Vázquez-Carrera M, et al. Avasimibe and atorvastatin synergistically reduce cholesteryl ester content in THP-1 macrophages. Eur J Pharmacol 2002; 451: 11-17.
42. Polo MP, de Bravo MG. Effect of geraniol on fatty acid and mevalonate metabolism in the human hepatoma cell line Hep G2. Biochem Cell Biol 2006; 84: 102-111.
43. Ren Z, Gould MN. Inhibition of ubiquinone and cholesterol synthesis by the monoterpene perillyl alcohol. Cancer Lett 1994; 76: 185-190.
44. Sinensky M, Beck LA, Leonard S, Evans R. Differential inhibitory effects of lovastatin on protein isoprenylation and sterol synthesis. J Biol Chem 1990; 265: 19937-19941.
45. Martinez-Botas J, Ferruelo AJ, Suarez Y, Fernandez C, Gómez-Coronado D, Lasunción MA. Dose-dependent effects of lovastatin on cell cycle progression. Distinct requirement of cholesterol, Non-sterol mevalonate derivatives. Biochim Biophys Acta 2001; 1532: 185-194.
46. Ness GC, Chambers CM, Lopez D. Atorvastatin action involves diminished recovery of hepatic HMG-CoA reductase activity. J Lipid Res 1998; 39: 75-84.
47. Carnesecchi S, Bradaia A, Fischer B, et al. Perturbation by geraniol of cell membrane permeability and signal transduction pathways in human colon cancer cells. J Pharmacol Exp Ther 2002; 303: 711-715.
48. Thibault A, Samid D, Tompkins AC, et al. Phase I study of lovastatin, an inhibitor of the mevalonate pathway, in patients with cancer. Clin Cancer Res 1996; 2: 483-491.
49. Miquel K, Pradines A, Tercé F, Selmi S, Favre G. Competitive inhibition of choline phosphotransferase by geranygeranil and farnesol inhibits phosphatidylcholine synthesis and induces apoptosis in human lung adenocarcinoma A549 cells. J Biol Chem 1998; 273: 26179-26186.